Is It Time to Draw the Curtain on Immune Intervention Trials in Newly Diagnosed Patients With IDDM?

Article navigation

Editorial| November 01 1995

Allan L Drash, MD

Division of Endocrinology, Metabolism and Diabetes Mellitus, Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania

Search for other works by this author on:

PubMed

Address correspondence and reprint requests to Allan L. Drash, MD, Children's Hospital of Pittsburgh, 3705 Fifth Ave., Pittsburgh, PA 15213.

Diabetes Care 1995;18(11):1499–1500

https://doi.org/10.2337/diacare.18.11.1499

PubMed:

8722077